Samy A K, Murray G, MacBain G
Department of Surgery, Garrick Hospital, Stranraer, UK.
J R Coll Surg Edinb. 1996 Apr;41(2):105-7.
The Glasgow Aneurysm Score (GAS), developed and published by the same authors, is a clinical prognostic scoring system that predicts mortality when operating on either intact or ruptured abdominal aortic aneurysms (AAA) taking into account these clinical criteria: patient's age, shock at presentation, myocardial disease, cerebrovascular disease and renal disease. The GAS was prospectively evaluated by studying 320 consecutive patients with AAA who were operated on at Glasgow, Aberdeen and Inverness, Scotland, in the period between January 1990 and May 1993. Logistic regression analysis showed very similar results to the original analysis used in developing the score. Age, shock, myocardial disease and renal disease were highly significant. Although it was not significant, cerebrovascular disease weight was not significantly different to its value in the original analysis. The mortality correlated well with the values of the score and ranged from 0% for scores below '70 GAS' to 80% for scores over '95 GAS'. The GAS appears, therefore, to be a reliable clinical predicative tool in foretelling the outcome of operating on AAA in terms of operative in-hospital mortality.
格拉斯哥动脉瘤评分（GAS）由同一批作者研发并发表，是一种临床预后评分系统，用于预测在对完整或破裂的腹主动脉瘤（AAA）进行手术时的死亡率，该评分系统考虑了以下临床标准：患者年龄、就诊时的休克情况、心肌病、脑血管疾病和肾病。通过研究1990年1月至1993年5月期间在苏格兰格拉斯哥、阿伯丁和因弗内斯接受手术的320例连续性AAA患者，对GAS进行了前瞻性评估。逻辑回归分析显示的结果与最初制定该评分时所使用的分析结果非常相似。年龄、休克、心肌病和肾病具有高度显著性。虽然脑血管疾病权重不具有显著性，但其数值与最初分析中的数值并无显著差异。死亡率与评分值密切相关，评分低于“70 GAS”时死亡率为0%，评分高于“95 GAS”时死亡率为80%。因此，就手术院内死亡率而言，GAS似乎是预测AAA手术结果的可靠临床预测工具。
